Mylexa is a biotech start-up, developing novel drugs for the treatment of allergic diseases such as hayfever and asthma.
The company owns protected intellectual property developed in the ANU. Strong alliances are being formed to promote rapid progression of this exciting technology. See www.mylexa.com
Related Articles